CASE STUDY

2025

+ CASE STUDY

2025

OVERVIEW

Case StUDY

Engagement. Insight. Impact.

Perigon’s Enhanced Services Program (ESP), powered by Medesto, doesn’t just fill prescriptions — it fills the gap between patient initiation and therapeutic success. This story is about what happens after the first script is written… and why it matters.

Image

OBJECTIVES

Real-Time Data

Collect and deliver unique, real-world patient data to inform manufacturers about therapy usage trends and patient perspectives.

Adherence

Improve patient adherence and persistence through targeted engagement and educational touchpoints.

Solutions

Proactively identify barriers to adherence and create pharmacist-driven solutions.

Clinical Support

Enhance the patient journey by providing additional layers of clinical support

OVERVIEW

Case StUDY

Engagement. Insight. Impact.

Perigon’s Enhanced Services Program (ESP), powered by Medesto, doesn’t just fill prescriptions — it fills the gap between patient initiation and therapeutic success. This story is about what happens after the first script is written… and why it matters.

Image

OBJECTIVES

Real-Time Data

Collect and deliver unique, real-world patient data to inform manufacturers about therapy usage trends and patient perspectives.

Adherence

Improve patient adherence and persistence through targeted engagement and educational touchpoints.

Solutions

Proactively identify barriers to adherence and create pharmacist-driven solutions.

Clinical Support

Enhance the patient journey by providing additional layers of clinical support

+ FROM PRESCRIPTION TO SILENCE

Where patients fall off, data disappears — We’re changing that.

+ FROM PRESCRIPTION TO SILENCE

Where patients fall off, data disappears — We’re changing that.

“Biopharma spends millions launching therapies, but what happens when patients don’t persist? When sample programs go untracked? When no one’s listening to what the patient is actually experiencing?”

Image

“Biopharma spends millions launching therapies, but what happens when patients don’t persist? When sample programs go untracked? When no one’s listening to what the patient is actually experiencing?”

Image

+ CHALLENGE

The gap between access, persistency, & real-world insights

A newly launched specialty therapy needed real-world data on patient behavior, adherence trends, and barriers to persistency. At the same time, patients needed better support navigating a chronic condition with limited existing resources.

+ CHALLENGE

The gap between access, persistency, & real-world insights

A newly launched specialty therapy needed real-world data on patient behavior, adherence trends, and barriers to persistency. At the same time, patients needed better support navigating a chronic condition with limited existing resources.

+ SOLUTION

 patient insight in real time
Image

Perigon deployed a tailored Enhanced Services Program through the Medesto Pulse our proprietary Patient Engagement Platform — built for high-touch specialty therapies and deep patient engagement.

We focused on 4 core goals:

  • Delivering real-world insights
  • Improving persistency
  • Elevating the patient journey
  • Empowering interventions

+ SOLUTION

 patient insight in real time
Image

Perigon deployed a tailored Enhanced Services Program through the Medesto Pulse our proprietary Patient Engagement Platform — built for high-touch specialty therapies and deep patient engagement.

We focused on 4 core goals:

  • Delivering real-world insights
  • Improving persistency
  • Elevating the patient journey
  • Empowering interventions

+ RESULTS THAT MATER

From engagement to outcomes 
Image
  • 217 newly referred patients in March 2025
  • 53% engagement rate — nearly double the expected benchmark
  • 28% improvement in patient-reported symptom burden within one month
    +53% INCREASE
    IN PERSISTENCY

+ RESULTS THAT MATTER

From engagement to outcomes 
Image
  • 217 newly referred patients in March 2025
  • 53% engagement rate — nearly double the expected benchmark
  • 28% improvement in patient-reported symptom burden within one month
    53% INCREASE
    IN PERSISTENCY

+ INSIGHTS DELIVERED

visibility into patient barriers, sample behavior, and care gaps.
Image
  • Which prescribers are (and aren’t) offering samples

  • Sample size variations by zip code and region

  • OTC usage trends and their impact on patient satisfaction

  • Real-world outcome feedback 

+ INSIGHTS DELIVERED

visibility into patient barriers, sample behavior, and care gaps.
Image
  • Which prescribers are (and aren’t) offering samples

  • Sample size variations by zip code and region

  • OTC usage trends and their impact on patient satisfaction

  • Real-world outcome feedback 

INTRIGUED?

CONTACT US TO SHEDULE A DEMO, OR REQUEST CASE STUDY

CONTACT US

Or Email Us: partners@perigonhealth.org

INTRIGUED?

CONTACT US TO SCHEDULE A DEMO, OR REQUEST CASE STUDY

CONTACT US
partners@perigonhealth.org
Image
Image